Company: BIVIW
Filing Date: 2025-08-11
Form Type: 8-K
Source: 0001520138-25-000249
Chunk: 2

Company: BIOVIE INC.
Filing Date: 2025-08-11
Form: 8-K
Item: Item 1.01
Chunk 2
---
 subject to customary exceptions and without the prior written consent of
the Underwriter, not to (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares
of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the
Company; (ii) file or cause to be filed any registration statement with the Commission relating to the offering of any shares of capital
stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company; (iii)
complete any offering of debt securities of the Company or (iv) enter into any swap or other arrangement that transfers to another, in
whole or in part, any of the economic consequences of ownership of capital stock of the Company. Moreover, the Company’s executive
officers and directors entered into lock-up agreements, pursuant to which they agreed, for a period of three (3) months from the date
of the Underwriting Agreement, subject to customary exceptions and without the prior written consent of the Underwriter, not to sell
or transfer any securities of the Company that they hold.

The Securities were offered and sold by the Company pursuant to the
Company’s Registration Statement on Form S-1, as amended (File No. 333-288525), filed by the Company with the U. S. Securities and
Exchange Commission (the “ SEC”) under the Securities Act, and declared effective on August 7, 2025.

The foregoing does not purport to be a complete description of each
of the Underwriting Agreement, the Warrants, the Pre-Funded Warrants, the Underwriter’s Warrants and the Warrant Agent Agreement,
and each is qualified in its entirety by reference to the full text of each of such document, which are filed as Exhibits 1.1, 4.1, 4.2,
4.3 and 10.1, respectively, to this Current Report on Form 8-K, and are incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities